Literature DB >> 2498930

Evidence that d-fenfluramine anorexia is mediated by 5-HT1 receptors.

J C Neill1, S J Cooper.   

Abstract

The effects of eight serotonin (5-HT) receptor antagonists on the anorectic effect of d-fenfluramine (3.0 mg/kg, IP) were examined in a test of sweet mash consumption, using non-deprived male rats. d-Fenfluramine's effect was attenuated by the mixed 5-HT1/5-HT2 receptor antagonists, methiothepin and metergoline; by the 5-HT2 receptor antagonist ritanserin; and by (+/-)cyanopindolol, a mixed 5-HT1A/5-HT1B receptor antagonist. In contrast, d-fenfluramine's effect was not antagonised by the 5-HT2 receptor antagonists ketanserin and ICI 169 369; the 5-HT3 receptor antagonist ICS 205 930; or by xylamidine, a peripheral 5-HT receptor antagonist. In this feeding model, none of the 5-HT antagonists, when tested alone, had any effect to increase palatable food consumption. The pattern of results obtained strongly suggest that central 5-HT1 receptors play an important role in the mediation of d-fenfluramine-induced anorexia.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2498930     DOI: 10.1007/bf00442252

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  34 in total

Review 1.  From fenfluramine racemate to d-fenfluramine. Specificity and potency of the effects on the serotoninergic system and food intake.

Authors:  S Garattini; T Mennini; R Samanin
Journal:  Ann N Y Acad Sci       Date:  1987       Impact factor: 5.691

2.  Inhibition of drug-induced anorexia in rats by methysergide.

Authors:  A M Barrett; L McSharry
Journal:  J Pharm Pharmacol       Date:  1975-12       Impact factor: 3.765

3.  Evidence for serotonergic modulation of sucrose sham-feeding in the gastric-fistulated rat.

Authors:  J C Neill; S J Cooper
Journal:  Physiol Behav       Date:  1988

4.  Receptor binding profile of R 41 468, a novel antagonist at 5-HT2 receptors.

Authors:  J E Leysen; F Awouters; L Kennis; P M Laduron; J Vandenberk; P A Janssen
Journal:  Life Sci       Date:  1981-03-02       Impact factor: 5.037

5.  Evidence for a difference in mechanism of action between fenfluramine- and amphetamine-induced anorexia.

Authors:  S Jespersen; J Scheel-Krüger
Journal:  J Pharm Pharmacol       Date:  1973-01       Impact factor: 3.765

6.  Peripherally administered serotonin decreases food intake in rats.

Authors:  J D Pollock; N Rowland
Journal:  Pharmacol Biochem Behav       Date:  1981-08       Impact factor: 3.533

7.  Ketanserin antagonises the anorectic effect of DL-fenfluramine in the rat.

Authors:  G Hewson; G E Leighton; R G Hill; J Hughes
Journal:  Eur J Pharmacol       Date:  1988-01-12       Impact factor: 4.432

8.  Receptor-binding properties in vitro and in vivo of ritanserin: A very potent and long acting serotonin-S2 antagonist.

Authors:  J E Leysen; W Gommeren; P Van Gompel; J Wynants; P F Janssen; P M Laduron
Journal:  Mol Pharmacol       Date:  1985-06       Impact factor: 4.436

9.  Peripheral and central mechanisms of action of serotoninergic anorectic drugs.

Authors:  M O Carruba; P Mantegazza; M Memo; C Missale; M Pizzi; P F Spano
Journal:  Appetite       Date:  1986       Impact factor: 3.868

10.  Effects of dl-fenfluramine and xylamidine on gastric emptying of maintenance diet in freely feeding rats.

Authors:  B J Baker; J P Duggan; D J Barber; D A Booth
Journal:  Eur J Pharmacol       Date:  1988-05-20       Impact factor: 4.432

View more
  29 in total

1.  Deconstructing antiobesity compound action: requirement of serotonin 5-HT2B receptors for dexfenfluramine anorectic effects.

Authors:  Sophie M Banas; Stéphane Doly; Katia Boutourlinsky; Silvina L Diaz; Arnauld Belmer; Jacques Callebert; Corinne Collet; Jean-Marie Launay; Luc Maroteaux
Journal:  Neuropsychopharmacology       Date:  2010-10-06       Impact factor: 7.853

2.  Effects of chronically administered fluoxetine and fenfluramine on food intake, body weight and the behavioural satiety sequence.

Authors:  J McGuirk; R Muscat; P Willner
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

Review 3.  Serotonergic drugs : effects on appetite expression and use for the treatment of obesity.

Authors:  Jason C G Halford; Joanne A Harrold; Emma J Boyland; Clare L Lawton; John E Blundell
Journal:  Drugs       Date:  2007       Impact factor: 9.546

4.  Evidence for 5-HT2 receptor mediation in quipazine anorexia.

Authors:  R Shukla; D MacKenzie-Taylor; R H Rech
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

5.  Studies on the role of serotonin receptor subtypes in the effect of sibutramine in various feeding paradigms in rats.

Authors:  G Grignaschi; E Fanelli; I Scagnol; R Samanin
Journal:  Br J Pharmacol       Date:  1999-07       Impact factor: 8.739

Review 6.  The utility of animal models to evaluate novel anti-obesity agents.

Authors:  Steven P Vickers; Helen C Jackson; Sharon C Cheetham
Journal:  Br J Pharmacol       Date:  2011-10       Impact factor: 8.739

Review 7.  The role of serotonin in eating disorders.

Authors:  S F Leibowitz
Journal:  Drugs       Date:  1990       Impact factor: 9.546

8.  Suppression of behavioral activity by norfenfluramine and related drugs in rats is not mediated by serotonin release.

Authors:  C W Callaway; L L Wing; D E Nichols; M A Geyer
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

9.  Ritanserin attenuates anorectic, endocrine and thermic responses to d-fenfluramine in human volunteers.

Authors:  E M Goodall; P J Cowen; M Franklin; T Silverstone
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

10.  Effects of d-fenfluramine and metergoline on responding for conditioned reward and the response potentiating effect of nucleus accumbens d-amphetamine.

Authors:  P J Fletcher
Journal:  Psychopharmacology (Berl)       Date:  1995-03       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.